[Impact of the pattern of lymph node metastasis on the clinical target volume in radiotherapy for thoracic esophageal squamous cell carcinoma]
- PMID: 20450594
[Impact of the pattern of lymph node metastasis on the clinical target volume in radiotherapy for thoracic esophageal squamous cell carcinoma]
Abstract
Objective: To study the pattern of lymph node metastasis of thoracic esophageal squamous cell carcinoma (ESCC) after esophagectomy and its impact on the clinical target volume (CTV) delineation in radiotherapy fpr thoracic ESCC.
Methods: The pattern of lymph node metastasis was retrospectively analyzed in 1077 patients with primary thoracic ESCC. All patients received esophagectomy with two- or three-field lymphadenectomy. The clinicopathologic factors related to lymph node metastasis were then analyzed using logistic regression analysis.
Results: The rates of cervical, upper mediastinal, middle mediastinal, lower mediastinal and abdominal cavity lymph node metastasis were 16.7%, 33.3%, 11.1%, 5.6% and 5.6%, respectively. The rates of those node metastasis in the middle thoracic ESCC were 4.0%, 3.8%, 28.5%, 7.1% and 17.1%, respectively, and the rates of those node metastasis in the lower thoracic ESCC were 1.5%, 3.0%, 22.7%, 37.0% and 33.2%, respectively. The depth of tumor invasion, histologic differentiation and the length of tumor were showed to be statistically most significant risk factors of lymph node metastasis of ESCC (P < 0.001).
Conclusion: The depth of tumor invasion, histologic differentiation, and length of tumor were closely correlated with lymph node metastasis of ESCC. All these factors and tumor location should be considered comprehensively when designing the target volume for radiotherapy.
Similar articles
-
Pattern of lymph node metastases and its implication in radiotherapeutic clinical target volume in patients with thoracic esophageal squamous cell carcinoma: A report of 1077 cases.Radiother Oncol. 2010 May;95(2):229-33. doi: 10.1016/j.radonc.2010.01.006. Epub 2010 Feb 25. Radiother Oncol. 2010. PMID: 20189259
-
[Lymphatic metastasis intensity of and lymphadenectomy for thoracic esophageal squamous cell carcinoma].Ai Zheng. 2006 May;25(5):604-8. Ai Zheng. 2006. PMID: 16687083 Chinese.
-
[Characteristics of the lymph node metastases and influencing factors and their value in target region delineation in postoperative radiotherapy for thoracic esophageal carcinoma].Zhonghua Zhong Liu Za Zhi. 2010 May;32(5):391-5. Zhonghua Zhong Liu Za Zhi. 2010. PMID: 20723441 Chinese.
-
Pattern of relapse following three-field lymphadenectomy of esophageal carcinoma and related factors predictive of recurrence.Cancer Radiother. 2023 May;27(3):189-195. doi: 10.1016/j.canrad.2022.09.001. Epub 2023 Feb 6. Cancer Radiother. 2023. PMID: 36754752 Review.
-
Involved-field radiotherapy for esophageal squamous cell carcinoma: theory and practice.Radiat Oncol. 2016 Feb 5;11:18. doi: 10.1186/s13014-016-0589-7. Radiat Oncol. 2016. PMID: 26846932 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical